-
1دورية أكاديمية
المؤلفون: Gabriella Liszkay, Catriona McNeil, Michele Maio, Vanna Chiarion-Sileni, Luc Thomas, Andrzej Mackiewicz, Michelle Del Vecchio, Ana Arance, Laurent Mortier, Lars Bastholt, Brigitte Dreno, Marta Nyakas, Michael Smylie, Christoph Hoeller, Virginia Ferraresi, Florent Grange, Joanna Pikiel, Fareeda Hosein, Burcin Simsek
المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
-
2
المؤلفون: Vanna Chiarion-Sileni, Céleste Lebbé, Catriona M. McNeil, Joanna Pikiel, Jean-Jacques Grob, Luc Thomas, Lars Bastholt, Andrzej Mackiewicz, Michele Maio, Omid Hamid, Virginia Ferraresi, Marta Nyakas, Caroline Robert, Michelle Del Vecchio, Burcin Simsek, Michael Smylie, Laurent Mortier, Dirk Schadendorf, Carmen Loquai, Inge Marie Svane, Ana Arance, Gabriella Liszkay, Fareeda Hosein, Piotr Rutkowski, Paolo A. Ascierto, Florent Grange, Christoph Hoeller, Brigitte Dréno, Ralf Gutzmer, Claus Garbe
المساهمون: Istituto Nazionale Tumori IRCCS Fondazione G. Pascale [Naples, Italy] (INT-FGP), IRCCS Istituto Nazionale dei Tumori [Milano], Poznan University of Medical Sciences [Poland] (PUMS), Institut Gustave Roussy (IGR), Université Paris-Sud - Paris 11 (UP11), Oncologie dermatologique, Département de médecine oncologique [Gustave Roussy], Institut Gustave Roussy (IGR)-Institut Gustave Roussy (IGR), Istituto Oncologico Veneto I.R.C.C.S. [Padova, Italy], Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Universitat de Barcelona (UB), CIC Saint Louis (CIC-1427), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Groupe Hospitalier Saint Louis - Lariboisière - Fernand Widal [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hopital Saint-Louis [AP-HP] (AP-HP), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Herlev and Gentofte Hospital, Copenhagen University Hospital, Royal Prince Alfred Hospital [Camperdown, Australia] (RPAH), Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology (MCMCC), University Medical Center [Mainz], Thérapies Laser Assistées par l'Image pour l'Oncologie - U 1189 (ONCO-THAI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire [Lille] (CHRU Lille), Hôpital Claude Huriez [Lille], CHU Lille, Odense University Hospital (OUH), Centre hospitalier universitaire de Nantes (CHU Nantes), University Hospital [Essen, Germany], German Cancer Consortium [Heidelberg] (DKTK), Eberhard Karls Universität Tübingen = Eberhard Karls University of Tuebingen, Oslo University Hospital [Oslo], Aix Marseille Université (AMU), Assistance Publique - Hôpitaux de Marseille (APHM), Centre Hospitalier Lyon Sud [CHU - HCL] (CHLS), Hospices Civils de Lyon (HCL), National Institute of Oncology [Budapest, Hungary], Cross Cancer Institute [Edmonton, AB, Canada], Medizinische Universität Wien = Medical University of Vienna, Regina Elena National Cancer Institute [Rome], Centre Hospitalier Universitaire de Reims (CHU Reims), Medizinische Hochschule Hannover (MHH), Wojewodzkie Centrum Oncologii [Gdańsk, Poland], Bristol-Myers Squibb [Princeton], University Hospital of Siena, Malbec, Odile
المصدر: Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer, 2020, 8 (1), pp.e000391. ⟨10.1136/jitc-2019-000391⟩
Ascierto, P A, Del Vecchio, M, Mackiewicz, A, Robert, C, Chiarion-Sileni, V, Arance, A, Lebbé, C, Svane, I M, Mcneil, C, Rutkowski, P, Loquai, C, Mortier, L, Hamid, O, Bastholt, L, Dreno, B, Schadendorf, D, Garbe, C, Nyakas, M, Grob, J J, Thomas, L, Liszkay, G, Smylie, M, Hoeller, C, Ferraresi, V, Grange, F, Gutzmer, R, Pikiel, J, Hosein, F, Simsek, B & Maio, M 2020, ' Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma ', Journal for ImmunoTherapy of Cancer, vol. 8, no. 1, e000391 . https://doi.org/10.1136/jitc-2019-000391Test
Ascierto, P A, Del Vecchio, M, Mackiewicz, A, Robert, C, Chiarion-Sileni, V, Arance, A, Lebbé, C, Svane, I M, Mcneil, C, Rutkowski, P, Loquai, C, Mortier, L, Hamid, O, Bastholt, L, Dreno, B, Schadendorf, D, Garbe, C, Nyakas, M, Grob, J J, Thomas, L, Liszkay, G, Smylie, M, Hoeller, C, Ferraresi, V, Grange, F, Gutzmer, R, Pikiel, J, Hosein, F, Simsek, B & Maio, M 2020, ' Overall survival at 5 years of follow-up in a phase III trial comparing ipilimumab 10 mg/kg with 3 mg/kg in patients with advanced melanoma ', Journal for immunotherapy of cancer, vol. 8, no. 1, e000391 . https://doi.org/10.1136/jitc-2019-000391Test
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)مصطلحات موضوعية: Cancer Research, medicine.medical_specialty, [SDV]Life Sciences [q-bio], Immunology, Medizin, Ipilimumab, randomized trials, Gastroenterology, Asymptomatic, law.invention, immunology, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, Clinical endpoint, Immunology and Allergy, 030212 general & internal medicine, Adverse effect, RC254-282, Clinical/Translational Cancer Immunotherapy, Pharmacology, business.industry, Incidence (epidemiology), Melanoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, oncology, [SDV] Life Sciences [q-bio], Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, medicine.symptom, business, Brain metastasis, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::510133352a63b0beb0ad853bb98c25dbTest
https://www.ncbi.nlm.nih.gov/pubmed/32503946Test